Menopause or More? The Hidden Health Risks of Overlooking Persistent Symptoms

Kerry Hatrill's life had always been a balancing act. At 49, she was juggling the demands of her job as a customer service assistant with the responsibilities of being a mother to two teenage sons. The fatigue that had crept into her days was easy to dismiss as a side effect of middle age. After all, wasn't this what life looked like when you reached your late 40s? The exhaustion, the bloating, the strange changes in her bowel habits—these were all things she could explain away. Menopause, she told herself, was the culprit. Articles in magazines and conversations with friends reinforced this idea: midlife brought hormonal shifts, mood swings, and a general sense of being out of sync with your body. So when the tiredness deepened and her stools began to change, she didn't see a doctor. Instead, she shrugged it off as another sign that life was catching up with her.

The symptoms, however, were not as benign as she believed. The bloating grew more persistent, and the fatigue became a constant companion, sapping her energy by midday. She noticed faint pink streaks in the toilet bowl after bowel movements but dismissed them as something trivial—perhaps a reaction to food or an unavoidable consequence of aging. When the urge to use the bathroom became more frequent and the stools thinned to pencil-like shapes, she still didn't see a pattern. Her GP initially reassured her after a stool test came back normal, and she left the appointment feeling relieved. But the unease lingered. The rectal pain that occasionally flared up, the sense of incomplete evacuation, and the relentless tiredness all felt like whispers from something deeper, something she wasn't ready to confront.

It wasn't until April 2024 that Kerry returned to her doctor, this time after a significant episode of bleeding. The red flag was low iron anaemia, a condition that prompted an urgent referral for a colonoscopy. During the procedure, doctors discovered a tumour in her rectum, roughly the size of a small orange. The diagnosis of stage three rectal cancer came a month later. Kerry, who had already been told the possibility of cancer, was surprisingly calm. "I felt prepared," she says. "I was ready with questions." But the emotional weight of the news hit hardest when she had to tell her sons, Jake, 28, and Craig, 25. "Telling my kids was incredibly hard because I couldn't guarantee what the outcome would be," she recalls. The fear of the unknown, the uncertainty of treatment, and the possibility of losing her children all weighed heavily on her.

Bowel cancer is a growing public health concern in both the UK and the US. In Britain, it is diagnosed in around 45,000 people annually and causes approximately 17,700 deaths each year, making it the second-most common cause of cancer death. In the United States, the numbers are even starker: an estimated 158,850 people will be diagnosed with colorectal cancer this year, and over 55,000 will die from it. While the disease has traditionally been associated with older adults, recent trends show a troubling rise in cases among younger people. In the UK, 45 per cent of bowel cancer diagnoses now occur in individuals under 65—a sharp increase from 27 per cent in 1995. In the US, one in five diagnoses occurs in people under 55.

Screening programs have been introduced to address this growing crisis. In Britain, everyone is offered a home screening test every two years starting at age 50. In the US, testing begins at age 45 and includes colonoscopies, which are considered the gold standard for detecting precancerous polyps. These procedures, when performed regularly, can prevent cancer by removing abnormalities before they progress. Yet for many, like Kerry, the symptoms were misinterpreted or ignored until it was too late. Her story underscores a broader issue: the need for greater awareness of bowel cancer symptoms and the importance of not dismissing changes in the body as simply part of aging. As she reflects on her journey, Kerry hopes her experience will serve as a warning to others. "If I had known earlier, maybe I could have caught it sooner," she says. "This is why I want to speak out.

The numbers are rising. Each year, around 2,500 Britons and 12,500 Americans under 50 are diagnosed with bowel cancer—figures that have doctors scratching their heads. While rates in older adults are declining, younger people are facing a surge in cases. What's behind this alarming trend? Could it be diet? Lifestyle? Or something more insidious? Cancer Research UK says the answer lies partly in what we're eating—or not eating. Red and processed meats, for instance, have been linked to higher risks, while fibre intake remains shockingly low. Adults need 30g of fibre daily, yet 96% fall short. Calcium, too, plays a role. A study suggests adding just 300mg—a glass of milk's worth—could slash cancer risk. But how many people are even aware of this?

Overweight, sedentary lifestyles, and smoking compound the problem. Yet the most critical factor may be early detection. If caught in stage one, 90% of patients survive. But once the cancer spreads to stage four, survival plummets to just 10%. For Kerry, a mother of two, the diagnosis was a wake-up call. "They said it was treatable," she recalls. "That gave me relief." Her battle began with chemotherapy, radiotherapy, and surgery—a grueling path that left her with peripheral neuropathy. Still, she fought on, driven by the hope of a cure. "Everything I went through felt worth it," she says, now on a five-year monitoring plan.

But for many, the journey ends too soon. Despite growing awareness, thousands of young women are diagnosed late, when treatment is no longer curable. Why? Because symptoms like fatigue, changes in bowel habits, and blood in stool often mimic hormonal shifts tied to childbirth or menopause. GPs and patients alike may dismiss them as "women's issues." Mel Schilling, a star of *Married At First Sight*, died last month at 54 from bowel cancer that had spread to her brain. She delayed seeing a doctor, believing her symptoms were due to menopause. Similarly, Dame Deborah James, a prominent campaigner, ignored hers for a year, attributing them to stress.

Genevieve Edwards, CEO of Bowel Cancer UK, says the problem is systemic. "Bowel cancer is still rare in younger women," she explains. "So when symptoms arise, GPs and patients often rule it out first." By the time a diagnosis is made, the cancer may be too advanced. Kerry now speaks out to change this. "I want to encourage others not to ignore symptoms," she says. But how many will listen? How many will see her story and realize that their own pain—whether from fatigue or blood in the stool—could be a red flag? The answer may determine whether the next generation of young people survives this deadly disease.

If you've ever felt a nagging unease after ignoring a persistent symptom, you're not alone. The human body is a complex machine, but sometimes it sends out clear signals—persistent changes in bowel habits, blood on toilet paper, unexplained bloating, or relentless fatigue—that demand attention. These aren't just random annoyances; they're red flags waving in the dark, warning of potential health crises that could be averted with timely intervention. Yet, for many, these signs are dismissed as temporary discomforts, a mistake that can have life-altering consequences.

Consider the case of a 32-year-old teacher who ignored intermittent abdominal pain for months, convinced it was just stress. By the time she sought help, her condition had progressed to a stage where treatment options were drastically limited. Her story is not unique. Across the country, healthcare professionals report a troubling trend: patients delay seeking care until symptoms become unbearable, often missing critical windows for early detection. This pattern isn't just a personal failing—it's a systemic issue rooted in public health messaging, access to care, and cultural attitudes toward medical help.

Government directives and regulatory frameworks play a pivotal role in shaping how individuals perceive and respond to these symptoms. Public health campaigns funded by federal agencies emphasize early detection as a cornerstone of disease prevention, yet gaps remain. In some regions, limited healthcare access forces people to endure symptoms for months before seeing a doctor. Others face barriers like high deductibles or lack of insurance, turning medical advice into an unattainable luxury. The result is a population that hears the warnings but often can't act on them, creating a tragic disconnect between knowledge and action.

The urgency of seeking help cannot be overstated. When symptoms persist for more than three weeks, they're no longer mere inconveniences—they're potential harbingers of serious conditions like colorectal cancer, inflammatory bowel disease, or other systemic illnesses. Early detection isn't just about survival; it's about quality of life. Treatments are far more effective when caught in the early stages, and the physical, emotional, and financial toll of delayed care can be devastating. Yet, for many, the fear of bad news or the stigma around certain conditions keeps them silent.

"You're never too young," insists Dr. Elena Martinez, a gastroenterologist who has seen patients as young as 25 with advanced colorectal cancer. "The body doesn't distinguish between ages when it comes to disease. If something feels wrong, trust that instinct." This advice is particularly vital in communities where health literacy is low or where cultural norms discourage open discussions about bodily functions. Government initiatives aimed at education and destigmatization are slowly shifting this narrative, but progress is uneven.

The message is clear: your body is speaking, and it's time to listen. Whether it's a change in bowel habits that lingers or a sudden wave of fatigue that won't subside, these signals are not to be ignored. They're invitations to take control of your health, to push past discomfort, and to demand answers from medical professionals. Early detection isn't just a medical imperative—it's a societal one. It requires individuals to act on their instincts and systems to ensure care is accessible, affordable, and prioritized. The difference between a life-saving diagnosis and a missed opportunity often hinges on these choices.